atm gene mutation

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

An Intervention to Increase Genetic Testing in Families Who May

Recruiting
  • BRCA1 Mutation
  • +21 more
  • Intervention Arm At-risk Relative/ARR Contacts
  • +5 more
  • Basking Ridge, New Jersey
  • +7 more
Nov 22, 2022

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Ataxia Telangiectasia, ATM Gene Mutation Trial in Nijmegen (Vitamin B3)

Completed
  • Ataxia Telangiectasia
  • ATM Gene Mutation
  • Vitamin B3
  • Nijmegen, Netherlands
    Radboudumc
Jul 21, 2022

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Prostatic Tumor, Prostate Cancer, BRCA2 Mutation Trial in Boston (Prostate cancer screening)

Recruiting
  • Prostatic Neoplasm
  • +7 more
  • Prostate cancer screening
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 30, 2021

ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation Trial in Canada, United States (Laboratory Biomarker Analysis,

Completed
  • ATM Gene Mutation
  • +20 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +1156 more
Jun 22, 2021

ATM Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial (Epacadostat, Pembrolizumab)

Withdrawn
  • ATM Gene Mutation
  • +9 more
  • (no location specified)
May 28, 2019